We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Mdxhealth Sa | LSE:0O8G | London | Ordinary Share | BE0974461940 | MDXHEALTH ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 38.90 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Dec 2022 to Dec 2024
NEWS RELEASE25 OCTOBER 2023, 4PM ET / 22:00 CET
MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8
Company to Host Conference Call with Live Q&A, November 8, 2023 at 4:30pm ET/ 22:30 CET
IRVINE, CA, and HERSTAL, BELGIUM – October 25, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today announced it will release its financial results for the third quarter and nine-month period ended September 30, 2023, after market close on Wednesday, November 8, 2023.
| Title: | MDxHealth Presents Third Quarter 2023 Financial Results and Corporate Update Conference Call and Webcast |
| Speakers: | Michael K. McGarrity, Chief Executive OfficerRon Kalfus, Chief Financial Officer |
| Date: | November 8, 2023 |
| Time: | 4:30pm ET/ 22:30 CET |
| Conference Call Dial-in Details: | United States: 1-888-886-7786Belgium: 0800 76018The Netherlands: 0800 022 7908United Kingdom: 4480 065 22435 |
| Conference ID: | 00680078 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1636749&tp_key=4b4cf524b1 |
The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.
About MDxHealthmdxhealth is a commercial-stage precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests are based on proprietary genomic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis and prognosis of urologic cancers and other urologic diseases. The Company’s U.S. headquarters and laboratory operations are in Irvine, California, with additional laboratory operations in Plano, Texas. European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.
For more information:
| MDxHealth info@mdxhealth.com | |
| LifeSci Advisors (IR & PR)US: +1 949 271 9223ir@mdxhealth.com |
NOTE: The mdxhealth logo, mdxhealth, Confirm mdx, Select mdx, Resolve mdx, Genomic Prostate Score, GPS and Monitor mdx are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners.
Attachment
1 Year Mdxhealth Chart |
1 Month Mdxhealth Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
